SNMI Chairman E. Prabhu palms over a memento to State Well being Secretary P. Senthil Kumar on the opening ceremony of the Nuclear Medication Convention held in Guindy on Thursday. |Picture courtesy of B. VELANKANNI RAJ
The Asia-Oceania Nuclear Medication and Biology Convention, organized by the Society of Nuclear Medication of India (SNMI), opened in Chennai on Thursday (December 4, 2025).
SNMI President E. Prabhu mentioned the convention introduced collectively 250 worldwide college, 450 nationwide college and 1,200 delegates and is a four-day occasion aimed toward spreading consciousness of nuclear medication and increasing nuclear medication companies in India.
Nuclear medication is a medical specialty that makes use of hint quantities of radioactive supplies for prognosis and therapy. Though India now has 540 nuclear medication facilities and is a longtime specialty, they nonetheless serve solely a small portion of the inhabitants and are largely concentrated within the personal sector, Dr. Prabhu mentioned.
Presently, 87% of nuclear medication facilities operate within the personal sector, however the majority of coaching happens in authorities establishments. “Presently, our 540 facilities serve a mean of 0.7 folks per million folks. Nuclear medication facilities in the US serve 4 folks per million, in comparison with 10 per million in Germany and 20 per million in Japan,” he famous.
Dr. Prabhu asserted that the necessity for better consciousness, better sponsorship and funding, in addition to progressive methods to broaden nuclear medication companies, are a number of the many points being mentioned in Parliament. “We are going to want 2,700 facilities to scale as much as not less than hundreds of thousands of individuals in India,” he mentioned.
Dr. Prabhu added that the Congress goals to convey collectively the perfect minds in nuclear medication below one roof and make nuclear remedy accessible to each residence that wants it.
